XML 62 R3.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Income Statement [Abstract]    
Net sales $ 168,872 $ 147,469
Cost of products sold 144,652 123,476
Gross profit 24,220 23,993
Operating expenses 26,828 25,309
Operating loss (2,608) (1,316)
Pension income (expense) 355 (1,153)
Other income, net 400 241
Interest expense (632) (389)
Loss before income taxes (2,485) (2,617)
Income tax expense 3,518 990
Net loss (6,003) (3,607)
Less: net earnings attributable to the non-controlling interest 123 65
Net loss attributable to Kewaunee Scientific Corporation $ (6,126) $ (3,672)
Net loss per share attributable to Kewaunee Scientific Corporation stockholders    
Basic (in usd per share) $ (2.20) $ (1.33)
Diluted (in usd per share) $ (2.20) $ (1.33)
Weighted average number of common shares outstanding    
Basic (in shares) 2,786 2,760
Diluted (in shares) 2,786 2,760